Abstract
Rheumatoid arthritis is associated with increased cardiovascular morbidity and mortality due to atherosclerosis. This cannot be explained by an increased presence of traditional risk factors but seems to depend on inflammatory mechanisms. The association of inflammatory pathways with atherosclerosis is complex, and more research is required to optimise preventative measures against cardiovascular complications in inflammatory rheumatic diseases.
Publication types
-
English Abstract
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Anti-Inflammatory Agents / therapeutic use
-
Anticholesteremic Agents / therapeutic use
-
Arthritis, Rheumatoid / complications*
-
Arthritis, Rheumatoid / drug therapy
-
Arthritis, Rheumatoid / immunology
-
Atherosclerosis / complications
-
Atherosclerosis / etiology
-
Cardiovascular Diseases / etiology*
-
Cardiovascular Diseases / mortality
-
Cardiovascular Diseases / prevention & control
-
Cytokines / immunology
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Inflammation Mediators / immunology
-
Risk Factors
Substances
-
Anti-Inflammatory Agents
-
Anticholesteremic Agents
-
Cytokines
-
Immunosuppressive Agents
-
Inflammation Mediators